Form 4: Dynavax Technologies Director Daniel L. Kisner Reports Acquisition and Disposal of Common Stock and Stock Options

Director Daniel L. Kisner reported acquiring 5,357 shares of common stock and disposing of 17,571 shares, while also acquiring 22,500 stock options in Dynavax Technologies Corp.

Summary

• On May 23, 2024, Daniel L. Kisner, a director of Dynavax Technologies Corp, reported transactions involving the company's securities.
• Kisner acquired 5,357 shares of common stock at $0 and disposed of 17,571 shares.
• Following these transactions, Kisner beneficially owns 17,571 shares of common stock.
• Kisner also acquired 22,500 stock options with an exercise price of $11.85, exercisable from May 22, 2031.
• These options vest one year from the grant date, contingent upon continued service to the company.
• The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The acquisition of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Negatives

• The disposal of 17,571 shares by a director could be interpreted negatively, although the context of the transaction is not fully clear from this report alone.

Risks

• The vesting of stock options and RSUs is contingent upon continued service to the company, creating a potential risk if the director leaves the company before the vesting date.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting of stock options and RSUs contingent on continued service suggests an expectation of the director's continued involvement with the company.

Industry Context

This filing is a routine disclosure related to insider trading activities, which are common in publicly traded companies. It provides transparency to investors regarding the transactions of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The vesting schedules and exercise prices of stock options are generally in line with industry norms for executive compensation.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company directors as it can provide insights into management's view of the company's prospects.

Key Dates